Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
NBE-002 for Breast Cancer
Recruiting1 awardPhase 1 & 2
Nashville, Tennessee
This trial is testing NBE-002, a new treatment that combines an antibody with a drug, in patients with advanced solid tumors. It works by targeting a specific protein on cancer cells to deliver the drug directly and kill the cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service